JONATHAN HARRY: Open Payments
NPI 1992852305 · MERCED, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 30 payments from 6 companies in 2025. Trend: 2023 $216 · 2024 $215 · 2025 $710
Food & beverage: $491Education: $219
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $438 |
| Alkermes, Inc. | 6 | $110 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: AUSTEDO XR, ARISTADA, COBENFY, UZEDY, INVEGA SUSTENNA, FANAPT, ABILIFY MAINTENA.
Industry payments across CA — which companies pay providers there.
